Over-and underexposure to cholesterol activates glia in neurodegenerative brain and retinal dis- 
| I N TR ODU C TI ON
The levels of free unesterified cholesterol content in the healthy CNS are relatively stable but excess or deficiency can result in inflammation and neurodegeneration. Cholesterol is a major risk factor for coronary artery disease, Huntington's disease, Alzheimer's disease as well as visual dysfunction in inherited retinal degenerations (Smith-Lemli-Opitz Syndrome [SLOS] , the Niemann-Pick type C disease), diabetic retinopathy and macular degeneration (Fliesler & Bretillon, 2010; Omarova et al,. 2012; Di Paolo & Kim, 2011; Thompson, 2015) . While the majority of CNS cholesterol is utilized for oligodendrocyte-mediated formation of myelin sheaths, this rigid amphipathic lipid with a flexible hydrocarbon tail plays key roles in the modulation of ion channels, vesicle cycling, dendritic spine development and production of Ab (Dietschy & Turley, 2004; Marquer et al., 2011; Mauch et al., 2001 ).
Because cholesterol-carrying lipoproteins are largely incapable of crossing the blood-brain barrier, neurons derive it mainly from in situ biosynthesis, particularly from glia which transport cholesterol via specialized carriers such as the ATP-binding cassette (ABC) transporters ABCA1 and ABCG1, lecithin-cholesterol acyltransferase (LCAT) and the sterol regulatory element-binding protein 2 (SREBP2) (van Deijk et al., 2017) .
Suppression of glioneuronal shuttling of cholesterol through astrocytespecific deletion of SREBP2 causes metabolic defects, altered brain development and abnormal cognition, social and motor behaviors (Ferris et al., 2017) .
In vertebrate retinas, cholesterol represents >98% of total sterols and is required for photoreceptor function and glia-dependent synapse formation (Fliesler et al., 2007; Mauch et al., 2001) . Reductions and oversupply of cholesterol through diet or as a result of genetic mutations can result in vision loss. For example, mutations in the biosynthetic enzyme -reductase) lower retinal cholesterol levels and trigger progressive neurodegeneration in SLOS (Fliesler & Bretillon, 2010) whereas increases in cholesterol levels (typically associated with cardiovascular disorders and diabetes) markedly increase the risk of neuropathy (Hammer & Busik, 2017) . Animals fed cholesterol-deprived or cholesterol-enriched diets show loss of RGCs and photoreceptors (Fliesler et al., 2007; Kretzer, Hitner, & Mehta, 1981; Triviño et al., 2006) , together with reactive activation, hypertrophy, and pathological swelling of M€ uller cells (Ramirez et al., 2006; Triviño et al., 2006) -radial glia that constitute a hub for de novo cholesterol biosynthesis, maintain the blood-retina barrier and serve as sentinels for metabolic, osmotic, mechanical and inflammatory signals within the retina (Byrne et al., 2013; Fliesler & Bretillon, 2010; Newman, 2015; Pannicke, Ivo Chao, Reisenhofer, Francke, & Reichenbach, 2016) . To gain insight into how cholesterol regulates M€ uller glial function under hypo-and hypercholesterolemic conditions, we investigated its role in the sensing of sensory cues mediated through TRPV4, a nonselective cation channel transducer of cell swelling, hydrostatic pressure, mechanical displacement and/or substrate strain (Ryskamp et al., 2016; Rocio Servin-Vences, Moroni, Lewin, & Poole, 2017; ToftBertelsen, Kri zaj, & MacAulay, 2017) , temperature (G€ uler et al., 2002) and natural/synthetic lipophilic compounds (reviewed in Redmon, Shibasaki, & Kri zaj, 2017; White et al., 2016) . TRPV4 was proposed to regulate Ca 21 influx through caveolin-1 (Cav-1)-enriched membrane domains in mesenteric endothelial cells (Saliez et al., 2008) . Cav-1 and/ or aquaporin 4 localized to glial lipid rafts (Kagawa et al., 2015) may interact with TRPV4 (Jo et al., 2015) but it is not clear how they influence the unique viscoelastic lipid microenvironment, glutamate transport and calcium signaling in these cells (Gu, Reagan, McClellan, & Elliott, 2017; Jo et al., 2015; Lu et al., 2006; Zschocke, Bayatti, & Behl, 2005 ). Here we report that, in contrast to the typically observed inhibition of ion channel activity (Levitan & Barrantes, 2012) , cholesterol facilitates TRPV4-mediated transduction of agonist and temperature stimuli whereas channel trafficking and membrane expression were unaffected by loss of caveolae and lipid rafts. C57BL/6J (C57) mice were maintained in a pathogen-free facility with a 12-hour light/dark cycle and ad libitum access to food and water.
| M A TE RI A L S A ND M E TH ODS
Data were gathered from male and female mice (P30-P120) without obvious differences in cell responsiveness to cholesterol modulation.
An abstract containing a portion of this work was published as Iuso, Jo, Yarishkin, Delic, and Kri zaj (2016).
| Reagents
The TRPV4 antagonist HC-067047 (HC-06) was purchased from Cayman Chemical. Salts and other reagents including the agonist GSK1016790A (GSK101) were obtained from Sigma or VWR. GSK101
(1 mM) and HC-06 (1 mM) stock aliquots were prepared in DMSO and subsequently diluted into working saline concentrations (25 nM and 1 mM, respectively).
| Retinal cell preparation
M€ uller cells were dissociated as described (Moln ar et al., 2016; . Following enucleation, retinas were dissected in cold L15 medium containing 20 mM D-glucose, 10 mM Na-HEPES, 2 mM Na-pyruvate, 0.3 mM Na-ascorbate, and 1 mM glutathione. Retinas were incubated in papain (7 U/mL; Worthington) for 1 hr at RT, washed in L15 and 500 lm squares were dissociated by gentle trituration. Cells were plated on concanavalin A-coated coverslips (1mg/mL) and loaded with Fura-2 AM (5-10 lM) for 45-60 min.
M€ uller cells were identified by their distinctive morphology, prominent Ca 21 signals during TRPV4 activation and/or postimaging immunocytochemistry (mouse anti-GS) (Jo et al., 2015; Moln ar et al., 2016) . Ratiometric imaging data was generally acquired from regions of interest (ROI) placed on the cell body.
Volume regulation in dissociated M€ uller cells was studied following published protocols (Jo et al., 2015; Ryskamp et al., 2014) . Anisosmotic solutions were prepared by addition or removal of mannitol to maintain the ionic strength of the extracellular solution and osmolarity checked thermometrically using a vapor pressure osmometer (Wescor, Logan, UT).
Removal of membranous cholesterol was based on the application of MbCD (Sigma-Aldrich), a cyclic oligosaccharide that binds it with high affinity (Christian, Haynes, Phillips, & Rothblat, 1997). The cyclodextrin was dissolved in L15 and used at 10 mM, the concentration shown to remove 80-90% of free membrane cholesterol (Levitan & Barrantes, 2012; Liu, Huang, Wu, & Priestley, 2006; Zidovetzki & Levitan, 2007) . To maximize extraction, the cells were preincubated with MbCD or MbCD saturated with cholesterol for 60 min (Romanenko et al., 2004) . Following incubation, cells were washed in L-15-containing saline and placed into recording chambers for electrophysiological or optical recordings. This protocol maintains decreased membrane cholesterol levels for at least 24 hr (Romanenko et al., 2004) . buffer (5% fetal bovine serum, 0.3% Triton X-100 dissolved in PBS).
Primary antibodies were diluted in the diluent (PBS with 2% BSA and 0.2% Triton X-100) and applied overnight at 48C. After rinsing, the cells were incubated with secondary antibodies diluted to 1:500 for one hour at RT. Antibodies: rabbit polyclonal TRPV4 (1:1000; LifeSpan Biosciences) validated in ocular tissues from Trpv4 -/-animals (Jo et al., 2015 Ryskamp et al., 2014) , mouse polyclonal caveolin-1
(1:100, BD Biosciences) validated in Cav1 -/-retinas (Li et al., 2012) 
| Electrophysiology
Retinal pieces were incubated in L-15 medium, and cells dissociated, plated and identified as described . (Jo et al., 2015) showed it to overlap with filipin in the perikaryon whereas TRPV4-ir puncta within the apical and distal processes were distinct from filipin signals . Thus, TRPV4 channels are not obligatorily trafficked to lipid rafts.
One hour incubation with 10 mM MbCD, a widely employed cholesterol extraction vehicle (Zidovetzki & Levitan, 2007) 
| Chronic removal of cholesterol inhibits agonistinduced TRPV4 activation
Given that TRPV4 is activated by many types of membrane-delimited events that include swelling, pressure, pulling and mechanical displacement (Jo et al., 2015; Matthews et al., 2010; Rocio Servin-Vences et al., 2017) and that its molecular structure-function may have co-evolved with key enzymes in cholesterol biosynthesis (Kumari et al., 2015) , we asked whether the activation of TRPV4 might be influenced by the levels of membrane cholesterol. M€ uller cells were incubated with MbCD for 1 hr to deplete their cholesterol levels (Figure 1 ), and exposed to the selective TRPV4 agonist GSK1016780A (GSK101) at its approximate EC 50 (25 nM) (Ryskamp et al., 2014) . In control saline, GSK101 ele- 
| Cholesterol depletion modulates the activation of glial TRPV4 channels
We recently showed that GSK101 serves an efficient effector of TRPV4-mediated membrane currents in dissociated M€ uller cells (Jo et al., 2015) . Here, we extend those studies by performing voltage clamp experiments under the more intact conditions of the intact (wholemount) retinal preparation. M€ uller end-feet forming the inner limiting membrane were whole cell-clamped at 6100 mV in the presence of K 1 -free Cs ] i . These findings identify a potential molecular mechanism through which dyslipidemia and/or abnormal glial sensing of ambient sensory inputs contribute to retinal pathology.
Our observation that lipid rafts and caveolae are distributed across every compartment of single M€ uller cells is consistent with observations in situ (Gu et al., 2017; Omarova et al., 2012) . MbCD treatment abrogated filipin fluorescence but had no effect on TRPV4-ir. The distinctiveness of filipin vis a vis TRPV4-ir puncta in M€ uller processes likewise suggests that, unlike TRPC1 (Brazer, Singh, Liu, Swaim, & Ambudkar, 2003) , TRPV4 trafficking/localization may not require cholesterol-rich and/or caveolar microdomains. In contrast to the disappearance of filipin signals in the presence of MbCD, the 50% decrease in Cav-1-ir probably reflects the shift of a protein fraction into nonraft domains (e.g., Krishnan & Chatterjee, 2013; Weerth, Holtzclaw, & Russell, 2007) . Similar observations were made for K Ca 1.1-3.1 and Kir2.1 channels, in which association with lipid rafts does not confer cholesterol sensitivity to cholesterol-insensitive mutants (Epshtein et al., 2009; Levitan, Singh, & Rosenhouse-Dantsker, 2014) . The results in glia (colocalization between Cav-1 and TRPV4; MbCD-dependent suppression of GSK101-induced Ca 21 signaling) are congruent with the report that Cav-1 facilitates 4a-PDD-induced TRPV4 activation in endothelial cells (Saliez et al., 2008) . Because swelling-induced TRPV4 activation was independent of cholesterol loss, we consider it unlikely that Cav-1 binding is obligatory for TRPV4 gating. This leads to the intriguing possibility that cholesterol-dependence of conformational transitions of the channel pore might depend on the manner in which the channel is activated (by temperature, swelling or chemical modulators) (Fantini, Di Scala, Evans, Williamson, & Barrantes, 2016; Lundbaek, Koeppe, & Andersen, 2010) . Cholesterol depletion could influence the local curvature of the bilayer by disrupting annular lipids that form hydrophobic pockets around the channel and/or SPFHdomain-containing proteins (stomatin, flotillin) that recruit cholesterol into the membrane (Anishkin, Loukin, Teng, & Kung, 2014; Gao, Cao, Julius, & Cheng, 2016; Levitan, Singh, & Rosenhouse-Dantsker, 2014 ).
Block of stretch-activated and TRPV1 channels by Grammostola spatulata (GsMtx4) and Ornithoctonus huwena (DkTx) venoms has been similarly attributed to the ability of toxins to partition into the lipid membrane and stabilize the open pore (Gao et al., 2016; Suchyna et al., 2004) . However, vanilloid TRPs may also be regulated through conserved cholesterol-binding CRAC (Cholesterol Recognition/Interaction Amino acid Consensus) domains that span the loop between TM4 and TM5 (amino acids 576 -632) of TRPV4 (Kumari et al., 2015) and CARC domains that mediate cholesterol binding in cognate TRPV1 (PicazoJu arez et al., 2011) . CARC-containing TRPV1 and inwardly rectifying Kir3.1/Kir3.4 (GIRK) channels are inhibited by MbCD (Bukiya, Durdagi, Noskov, & Rosenhouse-Dantsker, 2017; Liu, Huang, Wu, & Priestley, 2006; Szoke et al., 2010) whereas cholesterol increases the open probability but not the unitary conductance of GIRK channels that subserve cardiac K ACh currents (Bukiya et al., 2015) . The opposite effects were reported for Kir2.1-4 channels (Epshtein et al., 2009; Romanenko et al., 2004) , BK channels (Bolotina, Omelyanenko, Heyes, Ryan, & Bregestovski, 1989 ), Kv1.5 channels (Abi-Char et al., 2007) , N-type Ca 21 channels (Toselli et al., 2005) , volume-sensitive Cl -channels (Levitan, Christian, Tulenko, & Rothblat, 2000) and TRPM3/TRPM8 thermochannels (Morenilla-Palao, Pertusa, Meseguer, Cabedo, & Viana, 2009; Naylor et al., 2010; Wagner et al., 2008) in which MbCD enhances, whereas cholesterol inhibits, ion permeation.
A key finding was that raft domains, known to be important for glial signaling (Gu et al., 2017; Kagawa et al., 2015; Zschocke et al., 2017) (Levitan & Barrantes, 2012) . Of note, TRPV4 expressed in yeast (which cannot synthesize cholesterol) continues to be activated by changes in osmolarity, even as temperature sensitivity (which may require cholesterol) is lost (Loukin, Su, & Kung, 2009 (Li et al., 2004) or increased release from ER stores (Barrientos et al., 2015) . The quasi-linearity and slight outward rectification of TRPV4 currents in intact M€ uller cells differed from the "canonical" I-V phenotypes described in trabecular meshwork cells and TRPV4-transfected HEK293 cells (Ryskamp et al., 2016; Voets et al., 2002) but resembled the electrophysiological properties reported in chondrocytes, epithelial cells and TRPV4-transfected oocytes Rocio ServinVences et al., 2017; Toft-Bertelsen et al., 2017) . In contrast to cortical astroglia in which linearization of the TRPV4-mediated current required removal of extracellular Ca 21 (Benfenati et al., 2007) M€ uller cells, a crucial de novo retinal producer and supplier of cholesterol (Tserentsoodol et al., 2006; Zheng et al., 2012) , develop reactivity following either depletion (SLOS, Niemann-Pick's disease) or oversupply (diabetic retinopathy, glaucoma and macular degeneration) of this essential lipid (Fliesler et al., 2004; Fourgeux et al., 2014; Pikuleva & Curcio, 2014; Salazar et al., 2007) . Our finding that removal and supplementation of cholesterol impact on M€ uller glial capacity for transducing sensory information, further supports the rationale that cholesterol levels within the CNS must be maintained within a narrowly defined range to prevent Ca 21 dysregulation and reactivity (Martin et al., 2014) . The striking recovery of cone-mediated light responsiveness in the rat model of SLOS treated with cholesterol supplementation (Fliesler et al., 2007) suggests that sterol permeability of the blood-retina barrier exceeds the permeability of the blood-brain barrier (which excludes cholesterol; Pfrieger & Ungerer, 2011). Cholesterol-enriched diets and increases in plasma cholesterol (in cardiovascular disease and diabetes) can further increase barrier permeability and trigger abnormal retinal vascularization, osmotic swelling and overactivation of PLA2 (Hammer & Busik, 2017; Omarova et al., 2012; Pikuleva & Curcio, 2014; Triviño et al. 2006) . Hypercholesterolemic retinas show a striking resemblance to the effects of excessive TRPV4 activation (reactive gliosis, increased permeability of the retinal microvascular endothelial barrier, pathological glial swelling and RGC degeneration) (Jo et al., 2015; Phuong et al., 2016b; Ryskamp et al., 2014 Ryskamp et al., , 2016 . Accordingly, PLA2 blockers suppressed both M€ uller glial TRPV4 activation (Ryskamp et al., 2014) and the reactive response induced by hypercholesterolemia and diabetes mellitus (Acharya et al., 2017 ) whereas cholesterol-lowering drugs reduced the risk for contracting glaucoma (Marcus et al., 2012) which might involve TRPV4 overactivation (Kri zaj, 2016). Hence, TRPV4 channels could represent an auxiliary target in proinflammatory dyslipidemic pathologies.
ACKNOWLEDGMENT
Supported by: NIH (T32EY024234, AI; R01EY022076, R01EY02792 0; P30EY014800), Department of Defense (W81XWH-12-1-0244), 
